Latest DEF 14A proxy statements

Butterfly Network, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting of stockholders to be held virtually on June 18, 2026.

OceanFirst Financial Corp. has released its 2026 proxy statement detailing the upcoming annual meeting, executive compensation, and the proposed 2026 Stock Incentive Plan.

Sensei Biotherapeutics seeks stockholder approval for post-acquisition governance, share authorization, and equity plans following its merger with Faeth Therapeutics.

SCYNEXIS, Inc. has scheduled a special meeting for May 19, 2026, to seek stockholder approval for a reverse stock split to regain compliance with Nasdaq minimum bid price requirements.

Krispy Kreme's 2026 proxy statement outlines board changes, executive compensation, and proposals for the upcoming annual meeting.

Target Corporation has released its 2026 Proxy Statement, detailing the agenda for its upcoming Annual Meeting of Shareholders, including director elections, executive compensation, and shareholder proposals.

Coupang, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation.

Vivid Seats Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors and ratify auditor appointments.

Standard BioTools Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, with several key proposals for shareholder vote.

Seritage Growth Properties announces its 2026 Annual Meeting of Shareholders, detailing trustee elections, executive compensation, and auditor ratification.

Balchem Corporation has issued its 2026 Proxy Statement, inviting shareholders to its virtual Annual Meeting on June 18, 2026, to vote on director elections, auditor ratification, and executive compensation.

Functional Brands Inc. is holding a special meeting on May 28, 2026, to vote on a reverse stock split and a new equity incentive plan.

The RealReal, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, and is proposing several amendments to its Certificate of Incorporation, including phasing out its classified board structure.

GeoVax Labs announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, warrant exercise approvals, and auditor ratification.

Armata Pharmaceuticals, Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for June 11, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.

Aldeyra Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, ratify auditor appointments, and vote on executive compensation.

Biomea Fusion, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, to elect directors and ratify auditor appointment.

SharkNinja, Inc. has announced its 2026 Annual General Meeting, scheduled for June 18, 2026, with proposals including the re-appointment of seven directors and the ratification of its independent auditor.

Yext, Inc. invites stockholders to its 2026 Annual Meeting on June 10, 2026, to vote on director elections, auditor ratification, and executive compensation.

Rivian Automotive, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 22, 2026, with proposals including director elections and auditor ratification.

Annexon, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually, and is seeking approval to increase its authorized common stock.

CareDx, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to elect directors, ratify auditor appointment, and approve an amendment to increase shares available under its 2024 Equity Incentive Plan.

Enliven Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to address key corporate proposals including director elections and a significant increase in authorized shares.

QuidelOrtho Corporation has announced its 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to be held virtually.

Trupanion, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Ideal Power Inc. announces its 2026 Annual Meeting of Stockholders, to be held virtually on June 3, 2026, with key proposals including director elections and equity plan approval.

Cognition Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, to vote on director elections and auditor ratification.

Seres Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9th, to address key corporate matters including director elections and equity plan amendments.

Definium Therapeutics, Inc. announced its Annual General and Special Meeting of Shareholders will be held virtually on June 11, 2026, to elect directors, appoint auditors, and approve an equity incentive plan amendment.

Aclarion, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 4, 2026, detailing proposals for director elections, ratification of its auditor, and an amendment to its equity incentive plan.